Skip to main content
. 2013 Jun 2;17(4):438–443. doi: 10.1016/j.bjid.2012.12.006

Table 1.

Incident dyslipidemia by baseline demographic, behavioral and clinical characteristics, HIV patients on antiretroviral therapy, Vitoria, Brazil (n = 498).

Variables Dyslipidemiaa
n (%)
No dyslipidemia
n (%)
p-Value
Age (years)
 18–29 4 (3.6) 24 (6.2) 0.559
 30–49 72 (64.9) 239 (62.1)
 50 or more 35 (31.5) 122 (31.7)



Gender
 Male 62 (55.9) 247 (63.8) 0.149
 Female 49 (44.1) 140 (36.2)



Education (years)
 Up to 4 17 (15.3) 39 (10.2) 0.172
 More than 4 94 (84.7) 344 (89.8)



Tobacco use
 Yes 34 (31.5) 139 (37.5) 0.306
 No 74 (68.5) 232 (62.5)



Nadir CD4+ (cells/mL)
 Up to 200 68 (61.3) 224 (59.1) 0.742
 More than 200 43 (38.7) 155 (40.9)



Hypertension
 Yes 23 (20.7) 71 (18.5) 0.586
 No 88 (79.3) 312 (81.5)



Previous diabetes
 Yes 3 (2.7) 9 (2.3) 0.945
 No 108 (97.3) 375 (97.7)



HCV infection
 Yes 5 (4.5) 24 (6.3) 0.648
 No 106 (95.5) 357 (93.7)
a

Dyslipidemia: total cholesterol above 200 and HDL bellow 40 for men and 50 for women.